Health Care & Life Sciences » Pharmaceuticals | Polydex Pharmaceuticals Ltd.

Polydex Pharmaceuticals Ltd. | Income Statement

Fiscal year is February-January. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
5,963.80
5,376.00
6,040.40
6,621.30
5,279.00
4,942.60
Cost of Goods Sold (COGS) incl. D&A
4,525.50
4,148.80
4,596.90
4,811.80
3,991.40
4,022.20
Gross Income
1,438.30
1,227.20
1,443.40
1,809.50
1,287.60
920.40
SG&A Expense
775.80
711.90
901.50
821.30
714.40
682.90
EBIT
662.50
515.40
542.00
988.30
573.20
237.50
Non Operating Income/Expense
73.50
138.80
194.10
101.60
75.90
36.90
Interest Expense
76.90
91.40
42.60
38.00
33.80
35
Pretax Income
660.00
583.30
1,076.40
855.90
481.80
169.70
Income Tax
1.10
5.10
201.10
186.70
33.80
61.20
Consolidated Net Income
658.90
578.20
1,277.50
669.30
448.00
230.90
Net Income
658.90
578.20
1,277.50
669.30
448.00
230.90
Net Income After Extraordinaries
658.90
578.20
1,277.50
669.30
448.00
230.90
Net Income Available to Common
658.90
578.20
1,277.50
669.30
448.00
230.90
EPS (Basic)
0.21
0.18
0.38
0.20
0.13
0.07
Basic Shares Outstanding
3,186.00
3,265.50
3,343.00
3,390.20
3,409.70
3,419.50
EPS (Diluted)
0.20
0.17
0.37
0.19
0.13
0.07
Diluted Shares Outstanding
3,372.40
3,481.80
3,485.20
3,504.50
3,466.60
3,457
EBITDA
763.30
636.90
745.00
1,206.50
823.40
512.80
Non-Operating Interest Income
0.80
20.60
382.90
7.20
18.20
4.10

About Polydex Pharmaceuticals

View Profile
Address
421 Comstock Road
Toronto Ontario M1L 2H5
Canada
Employees -
Website http://www.polydex.com
Updated 07/08/2019
Polydex Pharmaceuticals Ltd. engages in the manufacture and sale of bulk quantities of dextran and derivative products to large pharmaceutical companies. It develops and market biotechnology-based products for the human pharmaceutical market. If focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.